WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2008100547) COMPOSITIONS COMPRISING LAMIRIDOSIN, IRIDOIDS OR DERIVATIVES THEREOF FOR TREATMENT OF HEPATITIS C OR HEPATITIS B
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2008/100547    International Application No.:    PCT/US2008/001912
Publication Date: 21.08.2008 International Filing Date: 13.02.2008
IPC:
A61K 31/35 (2006.01), A61K 31/352 (2006.01), C07D 311/00 (2006.01), A61P 1/16 (2006.01), A61P 31/12 (2006.01)
Applicants: NY FINANCIAL (INTERNATIONAL) CORPORATION [GB/GB]; c/o Moore Stephens, Palm Grove House, P.O. Box 3186, Wickhams Cay 1, Road Town, Tortola (VG) (For All Designated States Except US).
FONG, Harry [US/US]; (US) (For US Only)
Inventors: FONG, Harry; (US)
Agent: MERCHANT, Mary Anthony; Troutman Sanders LLP, Bank of America Plaza, 600 Peachtree Street, N.E., Suite 5200, Atlanta, GA 30308-2216 (US)
Priority Data:
60/901,602 13.02.2007 US
61/000,550 26.10.2007 US
Title (EN) COMPOSITIONS COMPRISING LAMIRIDOSIN, IRIDOIDS OR DERIVATIVES THEREOF FOR TREATMENT OF HEPATITIS C OR HEPATITIS B
(FR) COMPOSITIONS ET PROCÉDÉS POUR LE TRAITEMENT D'UNE PATHOLOGIE HÉPATIQUE
Abstract: front page image
(EN)The present invention comprises compositions and methods for the treatment of liver disease, particularly treatments for infection by HCV and/or HBV. The present invention comprises antiviral compositions comprising lamiridosin, derivatives of lamiridosin or iridoids that are effective in inhibiting one or more steps in the infection of cells by HCV or HBV. Methods for treating subjects, particularly humans, infected with HCV or HBV are provided.
(FR)L'invention concerne des compositions et des procédés pour le traitement d'une pathologie hépatique, notamment les traitements pour l'infection par le virus de l'hépatite C et/ou le virus de l'hépatite B. La présente invention comprend des compositions antivirales comprenant de la lamiridosine, des dérivés de la lamiridosine et des iridoïdes qui sont efficaces dans l'inhibition d'une ou plusieurs étapes de l'infection des cellules par le virus de l'hépatite C ou le virus de l'hépatite B. Des procédés de traitement des sujets, en particulier des êtres humains, infectés par le virus de l'hépatite C ou le virus de l'hépatite B sont prévus.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)